Financial Ratios

AMERISE BIOSCIENCES LTD.

NSE : NABSE : 531681ISIN CODE : INE673C01020Industry : Finance - InvestmentHouse : Private
BSE0.660 (0 %)
PREV CLOSE ( ) 0.66
OPEN PRICE ( ) 0.66
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43904
TODAY'S LOW / HIGH ( )0.66 0.66
52 WK LOW / HIGH ( ) 0.540.99
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.020.08-0.05-0.020.00
   CEPS(Rs)-0.020.08-0.05-0.020.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.840.850.770.820.84
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-0.220.35
   EBIT Margin(%)6.100.35
   Pre Tax Margin(%)6.100.35
   PAT Margin (%)6.100.35
   Cash Profit Margin (%)6.100.35
Performance Ratios
   ROA(%)-1.356.24-5.79-2.560.07
   ROE(%)-2.1310.24-6.41-2.710.07
   ROCE(%)-2.1010.17-6.41-2.700.07
   Asset Turnover(x)0.001.020.000.000.21
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.00-242.150.000.000.26
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.00
   Receivable days251.891106.76
   Inventory Days0.000.00
   Payable days138.11
Valuation Parameters
   PER(x)0.0016.370.000.000.00
   PCE(x)-38.9016.36-32.34-36.340.00
   Price/Book(x)0.841.592.141.000.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)1.015.58
   EV/Core EBITDA(x)-39.5716.48-32.30-36.261602.26
   EV/EBIT(x)-39.5716.48-32.30-36.261602.26
   EV/CE(x)0.830.761.930.901.18
   M Cap / Sales1.000.00
Growth Ratio
   Net Sales Growth(%)-100.00-100.00
   Core EBITDA Growth(%)-121.62263.13-126.52-3717.02119.37
   EBIT Growth(%)-121.62263.13-126.52-3717.02119.37
   PAT Growth(%)-121.65262.91-126.15-3725.15119.37
   EPS Growth(%)-121.66262.86-125.78-3866.67118.67
Financial Stability Ratios
   Total Debt/Equity(x)0.020.010.000.000.00
   Current Ratio(x)0.370.990.040.04180.09
   Quick Ratio(x)0.370.990.040.04180.09
   Interest Cover(x)-1188.001374.00-1631.54-445.17
   Total Debt/Mcap(x)0.020.010.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.